Company intelligence / Profile preview
Guanhao Biotech
Guangzhou, Guangdong, Chinaguanhaobio.com ↗
- Ownership
- Private
- Employees
- ~530
- Development stage
- Other
01
Overview
Guanhao Biotech markets several commercial regenerative medical devices and wound care products in China. Its small molecule drug Benvitimod has reached Phase 3 trials for dermatological indications. The company also has an mRNA-based COVID‑19 vaccine in discovery.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculemRNA vaccineProphylactic vaccineMedical device (biological patches, wound dressings, etc.)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Guanhao Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guanhao Biotech.